Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis

Exclusion Criteria

• •Hepatic decompensation：Including cirrhotic complications,such as ascites,hepatic encephalopathy,digestive tract bleeding,hepatorenal syndrome,spontaneous bacterial peritonitis,and HCC.
• •Complications of HBV,HCV,HIV.Complications of alcoholic liver disease,autoimmune liver disease,hereditary metabolic liver disease, drug-induced liver disease and other chronic liver disease.
• •AFP\>100ng/ml and imaging indicates malignant occupying.Or AFP still\>100ng/ml within 3 months.
• •Creatinine was 1.5 times higher than the upper limit of the normal value.
• •Combined with other malignant tumors(except those cured).
• •Serious diseases of heart, lung, kidney, brain, blood and other important organs with dysfunction.
• •severe neurological and psychiatric diseases (such as epilepsy, depression, mania, schizophrenia, etc.)
• •Pregnant women and breast-feeding women.
• •The researchers consider that it is not suitable for the patients to participate in this study.